Health
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study – PharmiWeb.com
New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose…
- New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced
- Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standard animal study
- Reduced COVID-19 replication by up to 96%, study performed by Public Health England (PHE) scientists
- Mode of action complementary to COVID-19 vaccines, with easy n…
Continue Reading
-
Noosa News20 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business22 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News21 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General21 hours agoInternal Revenue Service starts cutting 20,000 workers